IDH1 MUTATION

Clinical trials for IDH1 MUTATION explained in plain language.

Never miss a new study

Get alerted when new IDH1 MUTATION trials appear

Sign up with your email to follow new studies for IDH1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

New drug probe aims to measure niraparib's brain tumor penetration

Knowledge-focused Ongoing

This early-stage trial enrolls 16 adults with recurrent IDH-mutant gliomas who are scheduled for surgery. Participants take niraparib for one month before their operation so researchers can measure how much drug reaches the tumor and how it affects cancer cells. The goal is to ga…

Matched conditions: IDH1 MUTATION

Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused

Last updated May 22, 2026 14:02 UTC

IDH1 MUTATION

Get alerted when new IDH1 MUTATION trials appear

New drug probe aims to measure niraparib's brain tumor penetration